Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals

Background: The hepatitis C virus has a high mutation rate, which results in the emergence of resistance-associated substitutions (RASs). Despite direct-acting antivirals (DAAs) efforts to treat chronically infected HCV genotype 3 (GT3) patients, there are concerns about the emergence and persistenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mushtaq, Saima, Hashmi, Asraf Hussain, Khan, Amjad, Asad Raza Kazmi, Syed Muhammad, Manzoor, Sobia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091354/
https://www.ncbi.nlm.nih.gov/pubmed/35571102
http://dx.doi.org/10.3389/fphar.2022.894460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091354/
https://www.ncbi.nlm.nih.gov/pubmed/35571102
http://dx.doi.org/10.3389/fphar.2022.894460

Ejemplares similares